Explore more publications!
California Health Watch
Submit Press Release

California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on September 17, 2025

Silverado is Ranked 7th Nationwide in Fortune 2025 Best Workplaces in Aging Services in the Large Company Category.
September 17, 2025

Silverado is Ranked 7th Nationwide in Fortune 2025 Best Workplaces in Aging Services in the Large Company Category.

Indeterminate EIN Presswire
Bold Call to Action: 'Abortion and The Senseless Assault on Reproductive Rights'
September 17, 2025

Bold Call to Action: 'Abortion and The Senseless Assault on Reproductive Rights'

Indeterminate EIN Presswire
Payscout Integrates Digital Wallet into Epic’s MyChart for Enhanced Security and PCI Scope Reduction
September 17, 2025

Payscout Integrates Digital Wallet into Epic’s MyChart for Enhanced Security and PCI Scope Reduction

Indeterminate EIN Presswire
ShareWell Announces Free Access to Peer-Led Support Groups, Empowering Community for All
September 17, 2025

ShareWell Announces Free Access to Peer-Led Support Groups, Empowering Community for All

Indeterminate EIN Presswire
RealSeq Biosciences Awarded NIH SBIR Phase II Grant to Advance Breakthrough RNA Fragmentomics Platform
September 17, 2025

RealSeq Biosciences Awarded NIH SBIR Phase II Grant to Advance Breakthrough RNA Fragmentomics Platform

Indeterminate EIN Presswire
Qualiphy Highlights Shift From Good Faith Exams to Patient-Specific Orders in Aesthetic Care
September 17, 2025

Qualiphy Highlights Shift From Good Faith Exams to Patient-Specific Orders in Aesthetic Care

Indeterminate EIN Presswire
Introducing MCP Support Across Sikka.ai's Award-Winning API
September 17, 2025

Introducing MCP Support Across Sikka.ai's Award-Winning API

Indeterminate EIN Presswire
Autism Behavior Services, Inc. Celebrates 15 Years of Serving the Community
September 17, 2025

Autism Behavior Services, Inc. Celebrates 15 Years of Serving the Community

Indeterminate EIN Presswire
AllegroGraph Named a 2025 Trend Setting Product by KMWorld
September 17, 2025

AllegroGraph Named a 2025 Trend Setting Product by KMWorld

Indeterminate EIN Presswire
Viseon Inc. Announces Expansion to Transform Neurosurgical Brain Procedures
September 17, 2025

Viseon Inc. Announces Expansion to Transform Neurosurgical Brain Procedures

Indeterminate EIN Presswire
HMP Global’s Psych Congress Taps National Alliance on Mental Illness (NAMI) as 2025 Charitable Partner
September 17, 2025

HMP Global’s Psych Congress Taps National Alliance on Mental Illness (NAMI) as 2025 Charitable Partner

Indeterminate EIN Presswire
Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study
September 17, 2025

Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study

Indeterminate GlobeNewswire
Bionano Genomics, Inc. Announces Closing of $10 Million Public Offering
September 17, 2025

Bionano Genomics, Inc. Announces Closing of $10 Million Public Offering

Indeterminate GlobeNewswire
Eagle Pharmaceuticals Announces Availability of Proxy Materials and Audited Financial Statements for the 2023 and 2024 Fiscal Years
September 17, 2025

Eagle Pharmaceuticals Announces Availability of Proxy Materials and Audited Financial Statements for the 2023 and 2024 Fiscal Years

Indeterminate GlobeNewswire
Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Value Creation
September 17, 2025

Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Value Creation

Indeterminate GlobeNewswire
Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
September 17, 2025

Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe

Indeterminate GlobeNewswire
NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1
September 17, 2025

NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1

Indeterminate GlobeNewswire
NANOBIOTIX annonce de nouveaux résultats de Phase 1 évaluant JNJ-1900 (NBTXR3) en combinaison avec des inhibiteurs de points de contrôle en traitement de deuxième ligne ou plus chez des patients atteints de mélanome cutané résistant aux anti-PD-1
September 17, 2025

NANOBIOTIX annonce de nouveaux résultats de Phase 1 évaluant JNJ-1900 (NBTXR3) en combinaison avec des inhibiteurs de points de contrôle en traitement de deuxième ligne ou plus chez des patients atteints de mélanome cutané résistant aux anti-PD-1

Indeterminate GlobeNewswire
Vor Bio Announces Oral Presentation of 48-Week China Phase 3 Generalized Myasthenia Gravis Clinical Study at AANEM
September 17, 2025

Vor Bio Announces Oral Presentation of 48-Week China Phase 3 Generalized Myasthenia Gravis Clinical Study at AANEM

Indeterminate GlobeNewswire
CooperCompanies Announces Expanded Share Repurchase Program
September 17, 2025

CooperCompanies Announces Expanded Share Repurchase Program

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions